Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	platelet-derived growth factor receptor activity	PDGFRA PDGFRB	6.98e-05	3	97	2	GO:0005017
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	PDGFRA PDGFRB MST1R EPHB1	2.82e-04	65	97	4	GO:0004714
GeneOntologyMolecularFunction	extracellular matrix structural constituent	HSPG2 COL7A1 LAMC1 ZP2 HMCN2 HMCN1	3.12e-04	188	97	6	GO:0005201
GeneOntologyMolecularFunction	vascular endothelial growth factor binding	PDGFRA PDGFRB	3.46e-04	6	97	2	GO:0038085
GeneOntologyBiologicalProcess	cell-cell adhesion via plasma-membrane adhesion molecules	DSC3 DSG3 CDH23 SLITRK3 PLXNB2 HMCN2 HMCN1 ALCAM MDGA1	1.99e-05	313	99	9	GO:0098742
GeneOntologyBiologicalProcess	metanephric glomerulus morphogenesis	PDGFRA PDGFRB	6.82e-05	3	99	2	GO:0072275
GeneOntologyBiologicalProcess	metanephric glomerular capillary formation	PDGFRA PDGFRB	6.82e-05	3	99	2	GO:0072277
GeneOntologyBiologicalProcess	metanephric glomerulus vasculature morphogenesis	PDGFRA PDGFRB	6.82e-05	3	99	2	GO:0072276
GeneOntologyBiologicalProcess	VEGF-activated platelet-derived growth factor receptor signaling pathway	PDGFRA PDGFRB	6.82e-05	3	99	2	GO:0038086
GeneOntologyBiologicalProcess	positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway	PDGFRA PDGFRB	6.82e-05	3	99	2	GO:0038091
GeneOntologyCellularComponent	cell surface	SIGLEC12 PDGFRA PDGFRB LILRB2 SLITRK3 GRIN2A F2 PLXNB2 MILR1 MST1R LPA GLRB BTN1A1 PAM ALCAM BSN MDGA1 FERMT2 LRRC15	1.14e-06	1111	100	19	GO:0009986
GeneOntologyCellularComponent	collagen-containing extracellular matrix	HSPG2 LAMB4 COL7A1 LAMC1 F2 PLXNB2 ZP2 IGFBPL1 HMCN2 HMCN1 LPA PKM LRRC15	1.47e-06	530	100	13	GO:0062023
GeneOntologyCellularComponent	extracellular matrix	HSPG2 LAMB4 COL7A1 LAMC1 MUC5B F2 PLXNB2 ZP2 IGFBPL1 HMCN2 HMCN1 LPA PKM LRRC15	2.87e-06	656	100	14	GO:0031012
GeneOntologyCellularComponent	external encapsulating structure	HSPG2 LAMB4 COL7A1 LAMC1 MUC5B F2 PLXNB2 ZP2 IGFBPL1 HMCN2 HMCN1 LPA PKM LRRC15	2.97e-06	658	100	14	GO:0030312
GeneOntologyCellularComponent	basement membrane	HSPG2 LAMB4 COL7A1 LAMC1 HMCN2 HMCN1	2.66e-05	122	100	6	GO:0005604
GeneOntologyCellularComponent	cochlear hair cell ribbon synapse	CDH23 BSN	3.36e-04	6	100	2	GO:0098683
GeneOntologyCellularComponent	synaptic vesicle	DMXL2 SLC6A17 KIF1B GRIN2A MYOF SEPTIN1 BSN	5.99e-04	300	100	7	GO:0008021
GeneOntologyCellularComponent	external side of plasma membrane	SIGLEC12 PDGFRA LILRB2 F2 MILR1 LPA GLRB BTN1A1 ALCAM	8.60e-04	519	100	9	GO:0009897
GeneOntologyCellularComponent	exocytic vesicle	DMXL2 SLC6A17 KIF1B GRIN2A MYOF SEPTIN1 BSN	8.75e-04	320	100	7	GO:0070382
GeneOntologyCellularComponent	side of membrane	SIGLEC12 PDGFRA LILRB2 F2 MILR1 PTPN7 LPA GLRB BTN1A1 ALCAM MDGA1 FERMT2	9.56e-04	875	100	12	GO:0098552
GeneOntologyCellularComponent	GABA-ergic synapse	SLC6A17 SLITRK3 GLRB BSN MDGA1	1.16e-03	164	100	5	GO:0098982
GeneOntologyCellularComponent	exocytic vesicle membrane	DMXL2 SLC6A17 KIF1B MYOF BSN	1.70e-03	179	100	5	GO:0099501
GeneOntologyCellularComponent	synaptic vesicle membrane	DMXL2 SLC6A17 KIF1B MYOF BSN	1.70e-03	179	100	5	GO:0030672
GeneOntologyCellularComponent	Golgi lumen	HSPG2 MUC5B F2 PROZ	1.87e-03	109	100	4	GO:0005796
MousePheno	increased Schwann cell number	HSPG2 LAMC1 PRX	3.84e-06	6	82	3	MP:0010742
Domain	Ig-like_fold	SIGLEC12 HSPG2 FLNA COL7A1 PDGFRA PDGFRB LILRB2 PLXNB2 IGFBPL1 MILR1 TRIM3 MST1R HMCN2 HMCN1 BTN1A1 ALCAM MDGA1 EPHB1	2.86e-08	706	99	18	IPR013783
Domain	-	SIGLEC12 HSPG2 FLNA COL7A1 PDGFRA PDGFRB PLXNB2 IGFBPL1 MILR1 TRIM3 MST1R HMCN1 BTN1A1 ALCAM MDGA1 EPHB1	3.87e-07	663	99	16	2.60.40.10
Domain	IG	SIGLEC12 HSPG2 PDGFRA PDGFRB LILRB2 IGFBPL1 MILR1 HMCN2 HMCN1 BTN1A1 ALCAM MDGA1	2.32e-06	421	99	12	SM00409
Domain	Ig_sub	SIGLEC12 HSPG2 PDGFRA PDGFRB LILRB2 IGFBPL1 MILR1 HMCN2 HMCN1 BTN1A1 ALCAM MDGA1	2.32e-06	421	99	12	IPR003599
Domain	IGc2	SIGLEC12 HSPG2 PDGFRA PDGFRB IGFBPL1 HMCN2 HMCN1 ALCAM MDGA1	4.39e-06	235	99	9	SM00408
Domain	Ig_sub2	SIGLEC12 HSPG2 PDGFRA PDGFRB IGFBPL1 HMCN2 HMCN1 ALCAM MDGA1	4.39e-06	235	99	9	IPR003598
Domain	Ig_I-set	SIGLEC12 HSPG2 PDGFRA PDGFRB IGFBPL1 HMCN2 HMCN1 MDGA1	7.69e-06	190	99	8	IPR013098
Domain	I-set	SIGLEC12 HSPG2 PDGFRA PDGFRB IGFBPL1 HMCN2 HMCN1 MDGA1	7.69e-06	190	99	8	PF07679
Domain	IG_LIKE	SIGLEC12 HSPG2 PDGFRA PDGFRB LILRB2 IGFBPL1 MILR1 HMCN2 HMCN1 BTN1A1 ALCAM MDGA1	1.11e-05	491	99	12	PS50835
Domain	Ig-like_dom	SIGLEC12 HSPG2 PDGFRA PDGFRB LILRB2 IGFBPL1 MILR1 HMCN2 HMCN1 BTN1A1 ALCAM MDGA1	1.41e-05	503	99	12	IPR007110
Domain	KH_1	PCBP3 PCBP4 FUBP3 NOVA2	4.77e-05	38	99	4	PF00013
Domain	-	PCBP3 PCBP4 FUBP3 NOVA2	5.30e-05	39	99	4	3.30.1370.10
Domain	KH	PCBP3 PCBP4 FUBP3 NOVA2	5.86e-05	40	99	4	SM00322
Domain	KH_dom	PCBP3 PCBP4 FUBP3 NOVA2	5.86e-05	40	99	4	IPR004087
Domain	ig	SIGLEC12 HSPG2 PDGFRA PDGFRB HMCN1 ALCAM MDGA1	6.83e-05	190	99	7	PF00047
Domain	Immunoglobulin	SIGLEC12 HSPG2 PDGFRA PDGFRB HMCN1 ALCAM MDGA1	6.83e-05	190	99	7	IPR013151
Domain	KH_TYPE_1	PCBP3 PCBP4 FUBP3 NOVA2	7.12e-05	42	99	4	PS50084
Domain	KH_dom_type_1	PCBP3 PCBP4 FUBP3 NOVA2	8.57e-05	44	99	4	IPR004088
Domain	Kringle_CS	HGF F2 LPA	9.31e-05	17	99	3	IPR018056
Domain	KRINGLE_1	HGF F2 LPA	9.31e-05	17	99	3	PS00021
Domain	KR	HGF F2 LPA	9.31e-05	17	99	3	SM00130
Domain	Kringle	HGF F2 LPA	9.31e-05	17	99	3	IPR000001
Domain	KRINGLE_2	HGF F2 LPA	9.31e-05	17	99	3	PS50070
Domain	Kringle	HGF F2 LPA	9.31e-05	17	99	3	PF00051
Domain	G2F	HMCN2 HMCN1	1.66e-04	4	99	2	PF07474
Domain	NIDOGEN_G2	HMCN2 HMCN1	1.66e-04	4	99	2	PS50993
Domain	GFP	HMCN2 HMCN1	1.66e-04	4	99	2	IPR009017
Domain	G2_nidogen/fibulin_G2F	HMCN2 HMCN1	1.66e-04	4	99	2	IPR006605
Domain	Growth_fac_rcpt_	HSPG2 LAMC1 IGFBPL1 HMCN2 HMCN1 EPHB1	1.82e-04	156	99	6	IPR009030
Domain	-	DMXL2 WDR88 TAF1C PLXNB2 WDFY4 MST1R ARHGEF10 SON	3.93e-04	333	99	8	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	DMXL2 WDR88 TAF1C PLXNB2 WDFY4 MST1R ARHGEF10 SON	4.09e-04	335	99	8	IPR015943
Domain	Tyr_kinase_CSF1/PDGF_rcpt	PDGFRA PDGFRB	4.11e-04	6	99	2	IPR016243
Domain	EGF-like_CS	HSPG2 LAMB4 LAMC1 PROZ HMCN2 HMCN1 EPHB1	4.79e-04	261	99	7	IPR013032
Domain	EGF_2	HSPG2 LAMB4 LAMC1 PROZ HMCN2 HMCN1 EPHB1	5.24e-04	265	99	7	PS01186
Domain	EGF_LAM_2	HSPG2 LAMB4 LAMC1	5.29e-04	30	99	3	PS50027
Domain	EGF_LAM_1	HSPG2 LAMB4 LAMC1	5.29e-04	30	99	3	PS01248
Domain	Desmosomal_cadherin	DSC3 DSG3	5.74e-04	7	99	2	IPR009122
Domain	Kringle-like	HGF F2 LPA	6.41e-04	32	99	3	IPR013806
Domain	IGv	HSPG2 HMCN1 BTN1A1 ALCAM	6.77e-04	75	99	4	SM00406
Domain	Tyr_kinase_rcpt_3_CS	PDGFRA PDGFRB	7.63e-04	8	99	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	PDGFRA PDGFRB	7.63e-04	8	99	2	PS00240
Domain	LAMININ_IVA	HSPG2 LAMC1	7.63e-04	8	99	2	PS51115
Domain	Laminin_B	HSPG2 LAMC1	7.63e-04	8	99	2	PF00052
Domain	LamB	HSPG2 LAMC1	7.63e-04	8	99	2	SM00281
Domain	Laminin_IV	HSPG2 LAMC1	7.63e-04	8	99	2	IPR000034
Domain	EGF_Lam	HSPG2 LAMB4 LAMC1	8.36e-04	35	99	3	SM00180
Domain	Laminin_EGF	HSPG2 LAMB4 LAMC1	8.36e-04	35	99	3	PF00053
Domain	NHL_repeat_subgr	TRIM3 PAM	9.77e-04	9	99	2	IPR013017
Domain	WD40_repeat_dom	DMXL2 WDR88 TAF1C LRRK1 WDFY4 ARHGEF10 SON	1.02e-03	297	99	7	IPR017986
Domain	Laminin_EGF	HSPG2 LAMB4 LAMC1	1.07e-03	38	99	3	IPR002049
Domain	IG_FLMN	FLNA TRIM3	1.22e-03	10	99	2	SM00557
Domain	NHL_repeat	TRIM3 PAM	1.22e-03	10	99	2	IPR001258
Domain	NHL	TRIM3 PAM	1.22e-03	10	99	2	PF01436
Domain	Tyr_kinase_cat_dom	PDGFRA PDGFRB MST1R EPHB1	1.23e-03	88	99	4	IPR020635
Domain	TyrKc	PDGFRA PDGFRB MST1R EPHB1	1.23e-03	88	99	4	SM00219
Domain	C2-set_2	SIGLEC12 BTN1A1 ALCAM	1.33e-03	41	99	3	PF08205
Domain	CD80_C2-set	SIGLEC12 BTN1A1 ALCAM	1.33e-03	41	99	3	IPR013162
Domain	Filamin	FLNA TRIM3	1.48e-03	11	99	2	PF00630
Domain	FILAMIN_REPEAT	FLNA TRIM3	1.48e-03	11	99	2	PS50194
Domain	Filamin/ABP280_rpt	FLNA TRIM3	1.48e-03	11	99	2	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNA TRIM3	1.48e-03	11	99	2	IPR017868
Domain	PROTEIN_KINASE_TYR	PDGFRA PDGFRB MST1R EPHB1	1.77e-03	97	99	4	PS00109
Domain	Tyr_kinase_AS	PDGFRA PDGFRB MST1R EPHB1	1.77e-03	97	99	4	IPR008266
Domain	Coagulation_fac_subgr_Gla_dom	F2 PROZ	1.77e-03	12	99	2	IPR017857
Domain	-	F2 PROZ	1.77e-03	12	99	2	4.10.740.10
Domain	VWF_A	COL7A1 HMCN2 HMCN1 ANAPC1	1.90e-03	99	99	4	IPR002035
Domain	NHL	TRIM3 PAM	2.09e-03	13	99	2	PS51125
Domain	Ig_E-set	FLNA PLXNB2 TRIM3 MST1R	2.28e-03	104	99	4	IPR014756
Domain	EGF_1	HSPG2 LAMB4 LAMC1 PROZ HMCN2 HMCN1	2.37e-03	255	99	6	PS00022
Domain	GLA_1	F2 PROZ	2.43e-03	14	99	2	PS00011
Domain	GLA_2	F2 PROZ	2.43e-03	14	99	2	PS50998
Domain	Gla	F2 PROZ	2.43e-03	14	99	2	PF00594
Domain	GLA	F2 PROZ	2.43e-03	14	99	2	SM00069
Domain	GLA_domain	F2 PROZ	2.43e-03	14	99	2	IPR000294
Domain	Peptidase_S1A	HGF F2 PROZ LPA	3.08e-03	113	99	4	IPR001314
Domain	Laminin_N	LAMB4 LAMC1	3.18e-03	16	99	2	IPR008211
Domain	LamNT	LAMB4 LAMC1	3.18e-03	16	99	2	SM00136
Domain	LAMININ_NTER	LAMB4 LAMC1	3.18e-03	16	99	2	PS51117
Domain	Laminin_N	LAMB4 LAMC1	3.18e-03	16	99	2	PF00055
Domain	TRYPSIN_DOM	HGF F2 PROZ LPA	3.28e-03	115	99	4	PS50240
Domain	Tryp_SPc	HGF F2 PROZ LPA	3.48e-03	117	99	4	SM00020
Domain	Trypsin_dom	HGF F2 PROZ LPA	3.93e-03	121	99	4	IPR001254
Domain	Trypsin	HGF F2 PROZ LPA	3.93e-03	121	99	4	PF00089
Domain	Cation_ATPase_N	ATP13A4 ATP2A3	4.03e-03	18	99	2	PF00690
Domain	Cation_ATPase_N	ATP13A4 ATP2A3	4.03e-03	18	99	2	SM00831
Domain	EGF_CA	HSPG2 PROZ HMCN2 HMCN1	4.05e-03	122	99	4	SM00179
Domain	Ig_V-set	SIGLEC12 HSPG2 HMCN1 BTN1A1 ALCAM	4.16e-03	199	99	5	IPR013106
Domain	Peptidase_S1_PA	HGF F2 PROZ LPA	4.17e-03	123	99	4	IPR009003
Domain	EGF-like_Ca-bd_dom	HSPG2 PROZ HMCN2 HMCN1	4.29e-03	124	99	4	IPR001881
Domain	ATPase_P-typ_cation-transptr_N	ATP13A4 ATP2A3	4.48e-03	19	99	2	IPR004014
Domain	Pkinase_Tyr	PDGFRA PDGFRB MST1R EPHB1	4.93e-03	129	99	4	PF07714
Pubmed	Hemicentins assemble on diverse epithelia in the mouse.	DSC3 HMCN2 HMCN1	2.38e-08	3	101	3	17015624
Pubmed	Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression.	HSPG2 COL7A1 LAMC1 F2 PLXNB2 HMCN2 HMCN1 LPA	4.75e-08	175	101	8	28071719
Pubmed	Vertebrate extracellular matrix protein hemicentin-1 interacts physically and genetically with basement membrane protein nidogen-2.	LAMC1 HMCN2 HMCN1	9.49e-08	4	101	3	36007682
Pubmed	Protein profile of exosomes from trabecular meshwork cells.	HSPG2 FLNA LAMC1 MYOF PKM	3.22e-07	49	101	5	21362503
Pubmed	PDGFRβ regulates craniofacial development through homodimers and functional heterodimers with PDGFRα.	HSPG2 COL7A1 PDGFRA PDGFRB	3.86e-07	21	101	4	27856617
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	HSPG2 COL7A1 LAMC1 PLXNB2 HMCN2 HMCN1 LPA	6.11e-07	167	101	7	22159717
Pubmed	Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.	HGF PDGFRB MST1R EPHB1	1.30e-06	28	101	4	18593464
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	ALKBH4 HSPG2 FLNA LRRK1 PLXNB2 ADCY7 MST1R ORC1 PLEKHG1 MYOF INTS5 SLC45A3 ATP2A3 MED12	3.86e-06	1105	101	14	35748872
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	PDGFRA PDGFRB MST1R EPHB1	5.65e-06	40	101	4	30898150
Pubmed	Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis.	PDGFRA PDGFRB	8.35e-06	2	101	2	19333949
Pubmed	The fusion proteins TEL-PDGFRbeta and FIP1L1-PDGFRalpha escape ubiquitination and degradation.	PDGFRA PDGFRB	8.35e-06	2	101	2	19644140
Pubmed	Platelet-derived growth factor receptor expression and activation in choroid plexus tumors.	PDGFRA PDGFRB	8.35e-06	2	101	2	19717644
Pubmed	Structure, organization, and transcription units of the human alpha-platelet-derived growth factor receptor gene, PDGFRA.	PDGFRA PDGFRB	8.35e-06	2	101	2	8586421
Pubmed	Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.	PDGFRA PDGFRB	8.35e-06	2	101	2	11544480
Pubmed	A unique autophosphorylation site in the platelet-derived growth factor alpha receptor from a heterodimeric receptor complex.	PDGFRA PDGFRB	8.35e-06	2	101	2	7523122
Pubmed	The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms.	PCBP3 PCBP4	8.35e-06	2	101	2	12003487
Pubmed	Human cytomegalovirus downregulates expression of receptors for platelet-derived growth factor by smooth muscle cells.	PDGFRA PDGFRB	8.35e-06	2	101	2	17344284
Pubmed	A selection system for human apoptosis inhibitors using yeast.	POGK SON	8.35e-06	2	101	2	10509013
Pubmed	Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway.	LAMC1 PKM	8.35e-06	2	101	2	30755064
Pubmed	N-acetylcysteine suppresses retinal detachment in an experimental model of proliferative vitreoretinopathy.	PDGFRA PDGFRB	8.35e-06	2	101	2	20489144
Pubmed	Ligand-induced interaction between alpha- and beta-type platelet-derived growth factor (PDGF) receptors: role of receptor heterodimers in kinase activation.	PDGFRA PDGFRB	8.35e-06	2	101	2	1847074
Pubmed	Platelet-derived growth factor receptor: current views of the two-subunit model.	PDGFRA PDGFRB	8.35e-06	2	101	2	2161888
Pubmed	Roles of platelet-derived growth factor in the developing and mature nervous systems.	PDGFRA PDGFRB	8.35e-06	2	101	2	9233543
Pubmed	Platelet-derived growth factor may be associated with fibrosis in a Down syndrome patient with transient myeloproliferative disorder.	PDGFRA PDGFRB	8.35e-06	2	101	2	18331602
Pubmed	Inhibition of platelet-derived growth factor signaling prevents muscle fiber growth during skeletal muscle hypertrophy.	PDGFRA PDGFRB	8.35e-06	2	101	2	28129672
Pubmed	Interaction of vitamin K-dependent protein Z with thrombin. Consequences for the amidolytic activity of thrombin and the interaction of thrombin with phospholipid vesicles.	F2 PROZ	8.35e-06	2	101	2	2040612
Pubmed	Additive effects of PDGF receptor beta signaling pathways in vascular smooth muscle cell development.	PDGFRA PDGFRB	8.35e-06	2	101	2	14624252
Pubmed	PDGF receptors in tumor biology: prognostic and predictive potential.	PDGFRA PDGFRB	8.35e-06	2	101	2	25145436
Pubmed	Molecular analysis of PDGFRA and PDGFRB genes by rapid single-strand conformation polymorphism (SSCP) in patients with core-binding factor leukaemias with KIT or FLT3 mutation.	PDGFRA PDGFRB	8.35e-06	2	101	2	19035305
Pubmed	Structural determinants in the platelet-derived growth factor alpha-receptor implicated in modulation of chemotaxis.	PDGFRA PDGFRB	8.35e-06	2	101	2	8617789
Pubmed	Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer.	PDGFRA PDGFRB	8.35e-06	2	101	2	7665222
Pubmed	Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways.	PDGFRA PDGFRB	8.35e-06	2	101	2	2554309
Pubmed	An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency.	PDGFRA PDGFRB	8.35e-06	2	101	2	2531695
Pubmed	Survival-associated heterogeneity of marker-defined perivascular cells in colorectal cancer.	PDGFRA PDGFRB	8.35e-06	2	101	2	27248825
Pubmed	Platelet-derived growth factor receptor signaling is not involved in osteogenic differentiation of human mesenchymal stem cells.	PDGFRA PDGFRB	8.35e-06	2	101	2	19839721
Pubmed	Two different subunits associate to create isoform-specific platelet-derived growth factor receptors.	PDGFRA PDGFRB	8.35e-06	2	101	2	2542288
Pubmed	Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling.	PDGFRA PDGFRB	8.35e-06	2	101	2	29341790
Pubmed	Autocrine PDGFR signaling promotes mammary cancer metastasis.	PDGFRA PDGFRB	8.35e-06	2	101	2	16741576
Pubmed	Development of hygromas or severe edema during treatment with the tyrosine kinase inhibitor STI571 is not associated with platelet-derived growth factor receptor (PDGFR) gene polymorphisms.	PDGFRA PDGFRB	8.35e-06	2	101	2	15380338
Pubmed	Hepatocyte growth factor/c-Met signalling is important for the selection of transplanted hepatocytes.	HGF MST1R	8.35e-06	2	101	2	22287599
Pubmed	Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease.	PDGFRA PDGFRB	8.35e-06	2	101	2	17363728
Pubmed	Combined anti-PDGFRalpha and PDGFRbeta targeting in non-small cell lung cancer.	PDGFRA PDGFRB	8.35e-06	2	101	2	19115205
Pubmed	Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.	PDGFRA PDGFRB	8.35e-06	2	101	2	17145809
Pubmed	An automated and multiplexed method for high throughput peptide immunoaffinity enrichment and multiple reaction monitoring mass spectrometry-based quantification of protein biomarkers.	PDGFRA PDGFRB	8.35e-06	2	101	2	19843560
Pubmed	Cleavage of proteoglycans, plasma proteins and the platelet-derived growth factor receptor in the hemorrhagic process induced by snake venom metalloproteinases.	PDGFRA PDGFRB	8.35e-06	2	101	2	32737331
Pubmed	Transactivation of RON receptor tyrosine kinase by interaction with PDGF receptor beta during steady-state growth of human mesangial cells.	PDGFRB MST1R	8.35e-06	2	101	2	19242504
Pubmed	Vascular endothelial growth factor A competitively inhibits platelet-derived growth factor (PDGF)-dependent activation of PDGF receptor and subsequent signaling events and cellular responses.	PDGFRA PDGFRB	8.35e-06	2	101	2	22431518
Pubmed	Altered expression of desmocollin 3, desmoglein 3, and beta-catenin in oral squamous cell carcinoma: correlation with lymph node metastasis and cell proliferation.	DSC3 DSG3	8.35e-06	2	101	2	17846785
Pubmed	An allelic series at the PDGFalphaR locus indicates unequal contributions of distinct signaling pathways during development.	PDGFRA PDGFRB	8.35e-06	2	101	2	11782318
Pubmed	Mammalian hemicentin 1 is assembled into tracks in the extracellular matrix of multiple tissues.	HMCN2 HMCN1	8.35e-06	2	101	2	32035013
Pubmed	Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity.	PDGFRA PDGFRB	8.35e-06	2	101	2	22661233
Pubmed	Screening for diverse PDGFRA or PDGFRB fusion genes is facilitated by generic quantitative reverse transcriptase polymerase chain reaction analysis.	PDGFRA PDGFRB	8.35e-06	2	101	2	20107158
Pubmed	PDGFRalpha/beta expression correlates with the metastatic behavior of human colorectal cancer: a possible rationale for a molecular targeting strategy.	PDGFRA PDGFRB	8.35e-06	2	101	2	18288404
Pubmed	Calcitriol inhibits growth response to Platelet-Derived Growth Factor-BB in human prostate cells.	PDGFRA PDGFRB	8.35e-06	2	101	2	15862965
Pubmed	B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.	PDGFRA PDGFRB	8.35e-06	2	101	2	22697462
Pubmed	A new look at platelet-derived growth factor in renal disease.	PDGFRA PDGFRB	8.35e-06	2	101	2	18077793
Pubmed	Pigment epithelium-derived factor 34-mer peptide prevents liver fibrosis and hepatic stellate cell activation through down-regulation of the PDGF receptor.	PDGFRA PDGFRB	8.35e-06	2	101	2	24763086
Pubmed	Expression of platelet-derived growth factor receptor in low-grade endometrial stromal sarcomas in the absence of activating mutations.	PDGFRA PDGFRB	8.35e-06	2	101	2	17448020
Pubmed	Interaction of human protein Z with thrombin: evaluation of the species difference in the interaction between bovine and human protein Z and thrombin.	F2 PROZ	8.35e-06	2	101	2	1872862
Pubmed	Different PDGF Receptor Dimers Drive Distinct Migration Modes of the Mouse Skin Fibroblast.	PDGFRA PDGFRB	8.35e-06	2	101	2	30485861
Pubmed	Platelet-derived growth factor receptor expression and amplification in choroid plexus carcinomas.	PDGFRA PDGFRB	8.35e-06	2	101	2	18157090
Pubmed	Reduced expression of PDGF and PDGF receptors during impaired wound healing.	PDGFRA PDGFRB	8.35e-06	2	101	2	9242497
Pubmed	Platelet-derived growth factor receptor regulates salivary gland morphogenesis via fibroblast growth factor expression.	HSPG2 PDGFRA PDGFRB	8.45e-06	14	101	3	18559345
Pubmed	Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.	HGF FLNA PDGFRA PDGFRB LAMC1 F2 PTPN7 PKM	1.33e-05	371	101	8	25241761
Pubmed	In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine.	HSPG2 FLNA PCBP3 BDH2 LAMC1 MUC5B F2 MYOF PROZ HMCN1 PKM PAM LRRC15	1.37e-05	1070	101	13	23533145
Pubmed	Expression of CAF-Related Proteins Is Associated with Histologic Grade of Breast Phyllodes Tumor.	PDGFRA PDGFRB	2.50e-05	3	101	2	27881889
Pubmed	Distribution and evolution of von Willebrand/integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere.	HMCN2 HMCN1	2.50e-05	3	101	2	12388743
Pubmed	SM22α-lineage niche cells regulate intramembranous bone regeneration via PDGFRβ-triggered hydrogen sulfide production.	PDGFRA PDGFRB	2.50e-05	3	101	2	35508129
Pubmed	Embryonic mouse testis development: role of platelet derived growth factor (PDGF-BB).	PDGFRA PDGFRB	2.50e-05	3	101	2	15254974
Pubmed	Coexpression of PDGFR-alpha, PDGFR-beta and VEGF as a prognostic factor in patients with hepatocellular carcinoma.	PDGFRA PDGFRB	2.50e-05	3	101	2	21574155
Pubmed	PDGFRα/β and VEGFR2 polymorphisms in colorectal cancer: incidence and implications in clinical outcome.	PDGFRA PDGFRB	2.50e-05	3	101	2	23146028
Pubmed	The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence.	PDGFRA PDGFRB	2.50e-05	3	101	2	29380207
Pubmed	PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia.	COL7A1 PDGFRA	2.50e-05	3	101	2	21464317
Pubmed	Intron F G79A polymorphism of the protein Z gene in cancer patients with and without thrombosis.	F2 PROZ	2.50e-05	3	101	2	18246466
Pubmed	Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.	PDGFRA PDGFRB	2.50e-05	3	101	2	17298867
Pubmed	Conservation in sequence and affinity of human and rodent PDGF ligands and receptors.	PDGFRA PDGFRB	2.50e-05	3	101	2	8318539
Pubmed	Clinically relevant biomarkers to select patients for targeted inhibitor therapy after resection of hepatocellular carcinoma.	PDGFRA PDGFRB	2.50e-05	3	101	2	21590454
Pubmed	Identification of novel FLT3 kinase inhibitors.	PDGFRA PDGFRB	2.50e-05	3	101	2	23567961
Pubmed	Angioinhibitory action of NK4 involves impaired extracellular assembly of fibronectin mediated by perlecan-NK4 association.	HGF HSPG2	2.50e-05	3	101	2	19553700
Pubmed	Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.	PDGFRA PDGFRB	2.50e-05	3	101	2	18492696
Pubmed	PDGFR-β Plays a Key Role in the Ectopic Migration of Neuroblasts in Cerebral Stroke.	PDGFRA PDGFRB	2.50e-05	3	101	2	26435273
Pubmed	Expression and mutational analysis of tyrosine kinase receptors c-kit, PDGFRalpha, and PDGFRbeta in ovarian cancers.	PDGFRA PDGFRB	2.50e-05	3	101	2	15791568
Pubmed	Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.	PDGFRA PDGFRB	2.50e-05	3	101	2	9211853
Pubmed	Loss of T-cell protein tyrosine phosphatase induces recycling of the platelet-derived growth factor (PDGF) beta-receptor but not the PDGF alpha-receptor.	PDGFRA PDGFRB	2.50e-05	3	101	2	16971512
Pubmed	Adaptor protein Lnk binds to PDGF receptor and inhibits PDGF-dependent signaling.	PDGFRA PDGFRB	2.50e-05	3	101	2	21310211
Pubmed	A novel function of p53: a gatekeeper of retinal detachment.	PDGFRA PDGFRB	2.50e-05	3	101	2	22901751
Pubmed	Primary Cilia and Coordination of Receptor Tyrosine Kinase (RTK) and Transforming Growth Factor β (TGF-β) Signaling.	PDGFRA PDGFRB	2.50e-05	3	101	2	27638178
Pubmed	The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.	F2 LPA	2.50e-05	3	101	2	22422337
Pubmed	Effect of BSN-MST1 locus on inflammatory bowel disease and multiple sclerosis susceptibility.	MST1R BSN	2.50e-05	3	101	2	19657358
Pubmed	Administration of factor XIII B subunit increased plasma factor XIII A subunit levels in factor XIII B subunit knock-out mice.	F2 F13B	2.50e-05	3	101	2	18224415
Pubmed	A secreted protein promotes cleavage furrow maturation during cytokinesis.	HMCN2 HMCN1	2.50e-05	3	101	2	21215633
Pubmed	Cross-talk between the proto-oncogenes Met and Ron.	HGF MST1R	2.50e-05	3	101	2	10871856
Pubmed	Expression of tyrosine kinase receptors in malignant midgut carcinoid tumors.	PDGFRA PDGFRB	2.50e-05	3	101	2	17047316
Pubmed	Protein Z G79A and A-13G gene polymorphisms in Italian patients with Behçet's disease.	F2 PROZ	2.50e-05	3	101	2	19796528
Pubmed	Low to high Ca2+ -switch causes phosphorylation and association of desmocollin 3 with plakoglobin and desmoglein 3 in cultured keratinocytes.	DSC3 DSG3	2.50e-05	3	101	2	19348003
Pubmed	Combined inhibition of c-Abl and PDGF receptors for prevention and treatment of murine sclerodermatous chronic graft-versus-host disease.	PDGFRA PDGFRB	2.50e-05	3	101	2	22940072
Pubmed	PDGFRα/PDGFRβ signaling balance modulates progenitor cell differentiation into white and beige adipocytes.	PDGFRA PDGFRB	2.50e-05	3	101	2	29158445
Pubmed	Regulation of formation of factor XIIIa by its fibrin substrates.	F2 F13B	2.50e-05	3	101	2	2866798
Pubmed	Protein expression of platelet-derived growth factor receptor correlates with malignant histology and PTEN with survival in childhood gliomas.	PDGFRA PDGFRB	2.50e-05	3	101	2	18519768
Pubmed	Platelet-derived growth factor receptor association with Na(+)/H(+) exchanger regulatory factor potentiates receptor activity.	PDGFRA PDGFRB	2.50e-05	3	101	2	11046132
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SIGLEC12 HSPG2 PDGFRA PDGFRB IGFBPL1 HMCN2 HMCN1 MDGA1	1.75e-07	161	69	8	593
GeneFamily	Immunoglobulin like domain containing	HSPG2 PDGFRB MILR1 HMCN2 ALCAM MDGA1	9.39e-05	193	69	6	594
GeneFamily	Desmosomal cadherins	DSC3 DSG3	2.98e-04	7	69	2	1188
GeneFamily	Fibulins	HMCN2 HMCN1	3.96e-04	8	69	2	556
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	SIGLEC12 BTN1A1 ALCAM	4.75e-04	40	69	3	592
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	PDGFRA PDGFRB MST1R	4.75e-04	40	69	3	321
GeneFamily	Laminin subunits	LAMB4 LAMC1	9.24e-04	12	69	2	626
GeneFamily	Gla domain containing	F2 PROZ	1.09e-03	13	69	2	1250
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	PDGFRA POGK KIF1B TBC1D2B PLXNB2 INTS5 LPA SEPTIN1 ALCAM FERMT2 PCBP4 SON	1.24e-06	543	101	12	MM997
Coexpression	MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN	PDGFRA POGK KIF1B TBC1D2B PLXNB2 INTS5 SEPTIN1 ALCAM FERMT2 PCBP4 SON	5.27e-06	519	101	11	M3395
Coexpression	NABA_CORE_MATRISOME	HSPG2 LAMB4 COL7A1 LAMC1 ZP2 IGFBPL1 HMCN2 HMCN1	1.15e-05	275	101	8	M5884
Coexpression	NABA_BASEMENT_MEMBRANES	HSPG2 LAMB4 LAMC1 HMCN1	1.71e-05	40	101	4	M5887
Coexpression	NABA_MATRISOME	HGF HSPG2 LAMB4 COL7A1 LAMC1 MUC5B F2 PLXNB2 ZP2 IGFBPL1 F13B HMCN2 HMCN1 LPA	3.91e-05	1026	101	14	M5889
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	LRP12 CYP4F8 PDGFRA PDGFRB LAMC1 PLXNB2 PAM TCTN1 SON	6.97e-05	457	101	9	M1613
Coexpression	NABA_CORE_MATRISOME	HSPG2 COL7A1 LAMC1 ZP2 IGFBPL1 HMCN2 HMCN1	8.59e-05	270	101	7	MM17057
Coexpression	HEBERT_MATRISOME_TNBC_LUNG_METASTASIS	HSPG2 COL7A1 LAMC1	9.30e-05	23	101	3	M48001
Coexpression	CUI_TCF21_TARGETS_2_DN	KIF1B PPP1R13B GLCCI1 PRX PLEKHG1 MYOF STXBP3 PPIP5K2 FERMT2 ATP2A3 SON EPHB1	1.11e-04	854	101	12	M1533
Coexpression	NABA_ECM_GLYCOPROTEINS	LAMB4 LAMC1 ZP2 IGFBPL1 HMCN2 HMCN1	1.14e-04	196	101	6	M3008
Coexpression	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN	LILRB2 RUBCNL LAMC1 LRRK1 ALCAM KYNU	1.14e-04	196	101	6	M3085
Coexpression	GSE22886_NEUTROPHIL_VS_MONOCYTE_UP	RUBCNL PROZ MTAP GLRB HAO2 EPHB1	1.17e-04	197	101	6	M4466
Coexpression	GSE11057_PBMC_VS_MEM_CD4_TCELL_UP	LILRB2 RUBCNL PLXNB2 WDFY4 MYOF KYNU	1.17e-04	197	101	6	M3120
Coexpression	GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP	HSPG2 COL7A1 POGK PLXNB2 PPP2R5B MED12	1.24e-04	199	101	6	M7254
Coexpression	GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP	CYP4F8 RIPK4 LRRK1 MYOF ALCAM KYNU	1.24e-04	199	101	6	M5474
Coexpression	GSE3982_MAST_CELL_VS_DC_DN	KIF1B RIPK4 PLXNB2 MYOF ALCAM KYNU	1.24e-04	199	101	6	M5427
Coexpression	LIU_PROSTATE_CANCER_DN	HSPG2 FLNA COL7A1 CYP4F8 DSC3 BDH2 MYOF MYO15B FERMT2	1.24e-04	493	101	9	M19391
Coexpression	HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	FLNA COL7A1 PDGFRB LAMC1 FERMT2 LRRC15	1.27e-04	200	101	6	M5930
Coexpression	GSE360_DC_VS_MAC_L_MAJOR_UP	FLNA TBC1D2B MUC5B GRIN2A TRIM3 ORC1	1.27e-04	200	101	6	M5181
Coexpression	GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN	DMXL2 LILRB2 PLXNB2 MILR1 MYOF KYNU	1.27e-04	200	101	6	M3088
Coexpression	NABA_MATRISOME	HGF HSPG2 COL7A1 LAMC1 MUC5B F2 PLXNB2 ZP2 IGFBPL1 F13B HMCN2 HMCN1 LPA	1.33e-04	1008	101	13	MM17056
Coexpression	HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP	DSC3 RUBCNL KDM4B	1.52e-04	27	101	3	M2561
Coexpression	CHEN_METABOLIC_SYNDROM_NETWORK	FLNA LRP12 CYP4F8 PDGFRB LILRB2 RUBCNL FAM131A PLXNB2 WDFY4 ADCY7 MILR1 MYOF STXBP3 PKM PAM	1.53e-04	1316	101	15	MM1052
Coexpression	CUI_TCF21_TARGETS_2_DN	KIF1B PPP1R13B GLCCI1 PRX PLEKHG1 MYOF STXBP3 PPIP5K2 FERMT2 ATP2A3 SON EPHB1	1.59e-04	888	101	12	MM1018
Coexpression	VALK_AML_CLUSTER_12	HGF PCBP3 LAMC1	2.09e-04	30	101	3	M5516
Coexpression	HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED	COL7A1 LAMC1	2.18e-04	6	101	2	M48000
Coexpression	VALK_AML_CLUSTER_13	HSPG2 ADCY7 KDM4B	2.31e-04	31	101	3	M2603
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_100	HGF PDGFRA PDGFRB HMCN1 ALCAM	1.56e-07	27	100	5	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_100
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500	HGF PDGFRA PDGFRB GRIN2A MYOF HMCN1 PROKR2 ALCAM	7.44e-07	156	100	8	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_500	HGF FLNA PDGFRA PDGFRB MYOF HMCN1 PROKR2 ALCAM	1.14e-06	165	100	8	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_200	HGF PDGFRA MYOF HMCN1 ALCAM	1.55e-06	42	100	5	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_100	HGF PDGFRA PDGFRB HMCN1 PROKR2 ALCAM	1.57e-06	76	100	6	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_100
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB MYOF HMCN1 ALCAM	2.10e-06	125	100	7	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_500	HGF PDGFRA PDGFRB MYOF HMCN1 PROKR2 ALCAM	2.73e-06	130	100	7	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k2_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	HGF PDGFRB TBC1D2B PPP1R13B GRIN2A HMCN1 PROKR2 ALCAM	3.40e-06	191	100	8	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_k4_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB TBC1D2B BDH2 PPP1R13B GRIN2A PLXNB2 MYOF HMCN1 PROKR2 ZNF558 ALCAM WNK3	3.46e-06	777	100	15	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB TBC1D2B GRIN2A MYOF HMCN1 PROKR2 ALCAM	4.23e-06	336	100	10	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_500	HGF PDGFRA PDGFRB HMCN1 ALCAM	5.52e-06	54	100	5	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k2_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	HGF PDGFRA PDGFRB MYOF HMCN1 PROKR2 ALCAM	6.17e-06	147	100	7	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#2_top-relative-expression-ranked_200	PDGFRA PDGFRB MYOF HMCN1 PROKR2	8.57e-06	59	100	5	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k2_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#3_top-relative-expression-ranked_1000	HGF PDGFRA PDGFRB MYOF HMCN1 ALCAM	1.15e-05	107	100	6	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k3_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	FLNA PDGFRA PDGFRB TBC1D2B MYOF HMCN1 ALCAM	1.48e-05	168	100	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB MYOF HMCN1 PROKR2 ZNF558 ALCAM	1.59e-05	310	100	9	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB TBC1D2B PPP1R13B GRIN2A PLXNB2 MYOF HMCN1 PROKR2 ZNF558 ALCAM WNK3	2.06e-05	793	100	14	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB PLXNB2 DNAH7 ORC1 MYOF HMCN1 ZNF558 PAM ALCAM PPIP5K2 WNK3	2.18e-05	797	100	14	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500	HGF PDGFRA PDGFRB GRIN2A MYOF PROKR2 ALCAM	2.48e-05	182	100	7	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB PLXNB2 MYOF HMCN1 PROKR2 ZNF558	3.07e-05	337	100	9	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	Stem Cells, SC.STSL.BM, CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Bone marrow, avg-3	HGF DMXL2 PDGFRB BDH2 WDFY4 MYOF PAM ALCAM MDGA1 FGGY	3.10e-05	423	100	10	GSM399454_500
CoexpressionAtlas	Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4	HSPG2 UAP1 PDGFRA PDGFRB BDH2 LAMC1 MYOF HMCN1 PAM FERMT2	4.09e-05	437	100	10	GSM777046_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_200	PDGFRA PDGFRB MYOF HMCN1 PROKR2	4.29e-05	82	100	5	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500	HGF PDGFRA PDGFRB GRIN2A MYOF HMCN1 PROKR2 ALCAM WNK3	4.71e-05	356	100	9	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200	PDGFRA PDGFRB MYOF HMCN1 PROKR2 WNK3	4.88e-05	138	100	6	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200
CoexpressionAtlas	dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	HGF PDGFRA PDGFRB GRIN2A MYOF HMCN1 PROKR2 ALCAM WNK3	5.24e-05	361	100	9	gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_500	HGF FLNA PDGFRA PDGFRB MYOF HMCN1 PROKR2 ALCAM WNK3	5.59e-05	364	100	9	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_500
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	HGF FLNA PDGFRA PDGFRB MYOF HMCN1 PROKR2	5.62e-05	207	100	7	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4	HGF HSPG2 DSC3 PDGFRA PDGFRB LAMC1 PLXNB2 MYOF PAM FERMT2	5.73e-05	455	100	10	GSM777055_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500	HGF PDGFRA PDGFRB PPP1R13B MYOF HMCN1 PROKR2 ALCAM WNK3	6.74e-05	373	100	9	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500
CoexpressionAtlas	Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5	HSPG2 DSC3 PDGFRA PDGFRB LAMC1 PLXNB2 MYOF HMCN1 PAM FERMT2	6.99e-05	466	100	10	GSM777050_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_200	HGF PDGFRA MYOF HMCN1 PROKR2 ALCAM	8.66e-05	153	100	6	gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	FLNA CYP4F8 PDGFRA PDGFRB TBC1D2B PLXNB2 MYOF HMCN1 ZNF558 PAM ALCAM PPIP5K2 WNK3	9.31e-05	797	100	13	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	ALKBH4 HGF PDGFRA PDGFRB POGK KIF1B LAMC1 RIPK4 HMCN1 PROKR2 ANAPC1 GLRB FERMT2	1.04e-04	806	100	13	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB PPP1R13B PLXNB2 DNAH7 ORC1 MYOF HMCN1 PROKR2 ZNF558 WNK3	1.34e-04	827	100	13	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_k-means-cluster#4_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB ADCY7 MYOF HMCN1 ZNF558	1.58e-04	327	100	8	gudmap_dev gonad_e11.5_F_GonMes_Sma_k4_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_500	HGF FLNA PDGFRA PDGFRB ORC1 MYOF HMCN1 PROKR2 WNK3	1.60e-04	418	100	9	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_500
CoexpressionAtlas	kidney_adult_RenalCortexMixed_Std_k-means-cluster#4_top-relative-expression-ranked_200	BDH2 F13B HAO2 FGGY	1.73e-04	59	100	4	gudmap_kidney_adult_RenalCortexMixed_Std_k4_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_200	PDGFRA PDGFRB HMCN1	2.44e-04	26	100	3	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k4_200
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	FLNA PDGFRA PDGFRB MYOF HMCN1 ZNF558 ALCAM	2.60e-04	265	100	7	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB TBC1D2B GRIN2A MYOF HMCN1 PROKR2 ZNF558 ALCAM WNK3	2.78e-04	773	100	12	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB PLXNB2 ORC1 MYOF HMCN1 PAM ALCAM PPIP5K2 WNK3	3.12e-04	783	100	12	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	UAP1 PDGFRB KIF1B LAMC1 ANAPC1 FERMT2 SON EPHB1	4.73e-04	385	100	8	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	kidney_P2_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500	HMCN1 GLRB ALCAM	5.45e-04	34	100	3	gudmap_kidney_P2_CapMes_Crym_k2_500
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200	PDGFRA PDGFRB MYOF HMCN1 PROKR2	6.39e-04	146	100	5	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_k-means-cluster#4_top-relative-expression-ranked_500	PDGFRA PDGFRB MYOF HMCN1 ALCAM	6.39e-04	146	100	5	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_k4_500
CoexpressionAtlas	dev gonad_e11.5_M_GonMes_Sma_k-means-cluster#3_top-relative-expression-ranked_1000	HGF PDGFRA PDGFRB MYOF HMCN1 PROKR2 ZNF558	6.76e-04	311	100	7	gudmap_dev gonad_e11.5_M_GonMes_Sma_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000	HGF PDGFRA PDGFRB POGK KIF1B LAMC1 ANAPC1	6.89e-04	312	100	7	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2
CoexpressionAtlas	dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_100	PDGFRA PDGFRB PROKR2	7.01e-04	37	100	3	gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_100
CoexpressionAtlas	dev gonad_e11.5_F_GonMes_Sma_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB DNAH7 ADCY7 ORC1 MYOF HMCN1 ZNF558 PPIP5K2 WNK3	7.04e-04	858	100	12	gudmap_dev gonad_e11.5_F_GonMes_Sma_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_k-means-cluster#2_top-relative-expression-ranked_1000	DSC3 POGK MTAP PROKR2 GLRB	7.23e-04	150	100	5	gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_1000_k2
CoexpressionAtlas	Stromal Cells, Ep.MEChi.Th, CD45-EpCAm+Ly51-MHCIIhi, Thymus, avg-1	UAP1 DSC3 ZP2 PLEKHG1 PROKR2 PAM ALCAM KYNU	7.26e-04	411	100	8	GSM854302_500
CoexpressionAtlas	Myeloid Cells, DC.8-4-11b-.SLN, CD11b-FITC CD4-PE CD11c-eFluor780 CD8a-eFluor450 C, Lymph Node, avg-3	UAP1 RUBCNL LRRK1 PLXNB2 WDFY4 MYOF STXBP3 KYNU	8.10e-04	418	100	8	GSM854291_500
CoexpressionAtlas	kidney_P0_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_500	HMCN1 GLRB ALCAM	8.82e-04	40	100	3	gudmap_kidney_P0_CapMes_Crym_k1_500
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	HGF FLNA PDGFRA PDGFRB PPP1R13B MYOF HMCN1 PROKR2 ZNF558 ALCAM WNK3	9.79e-04	768	100	11	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3	HGF UAP1 FAM78B PLXNB2 MST1R MYOF PAM ALCAM	1.09e-03	438	100	8	GSM605850_500
CoexpressionAtlas	Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4	HSPG2 LAMC1 PLEKHG1 HMCN1 SLC45A3 ARHGEF10 PAM FERMT2	1.11e-03	439	100	8	GSM777059_500
CoexpressionAtlas	Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3	HSPG2 PDGFRA PDGFRB LAMC1	1.15e-03	97	100	4	GSM777043_100
CoexpressionAtlas	Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	DSC3 PDGFRA PDGFRB BDH2 LAMC1 RIPK4 F2 TRIM3 MYOF PROZ SLC45A3 LPA KYNU	1.28e-03	1049	100	13	PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05
CoexpressionAtlas	Stromal Cells, LEC.SLN, gp38+ CD31+, Lymph Node, avg-4	HSPG2 LAMC1 PLEKHG1 HMCN1 SLC45A3 ARHGEF10 PAM FERMT2	1.30e-03	450	100	8	GSM777063_500
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 PDGFRA PDGFRB LAMC1 MYOF HMCN2 HMCN1 ARHGEF10 PAM FERMT2 LRRC15	1.02e-12	198	101	11	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSC3 RUBCNL WDFY4 ADCY7 MILR1 KYNU EPHB1	6.03e-08	153	101	7	c81a88d3f707487c511020d3960a1c41e706c6a0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RUBCNL LRRK1 WDFY4 GLCCI1 PTPN7 PROKR2 ATP2A3	1.40e-07	173	101	7	62ba49c1c16760a8c6cde0cc44e068f94386946a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 RUBCNL LRRK1 WDFY4 ADCY7 MILR1 KYNU	1.57e-07	176	101	7	926ed37e636fe4dd3a18731cea15761f0c2c285a
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA SLITRK3 MYOF HMCN2 GLRB ALCAM FERMT2	2.93e-07	193	101	7	0256e8fe4a47f2e2a43ef9d19bfc047d20806d69
ToppCell	COVID-19-Heart-Macrophage\|Heart / Disease (COVID-19 only), tissue and cell type	DMXL2 LILRB2 RUBCNL WDFY4 ADCY7 ALCAM KYNU	3.04e-07	194	101	7	f09675cd472200363c458952f00d2e41990800ee
ToppCell	Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell\|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	RUBCNL LRRK1 WDFY4 PLEKHG1 ATP2A3 KYNU KDM4B	3.04e-07	194	101	7	ff661419b697aef51a53fdeac8d37d870d65f491
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 RUBCNL LRRK1 WDFY4 ADCY7 MILR1 KYNU	3.14e-07	195	101	7	ce8215d503cad3a9bc7d5d2be4adb57408015593
ToppCell	COVID-19-Lymphoid-pDC\|Lymphoid / Condition, Lineage and Cell class	HSPG2 RUBCNL LRRK1 WDFY4 MILR1 KYNU EPHB1	3.14e-07	195	101	7	4a7c080230ce6a79335ecbeadecb0177b2c13625
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 RUBCNL LRRK1 WDFY4 ADCY7 MILR1 KYNU	3.14e-07	195	101	7	09df40ff9b493170861b3f6e57a942a834655b5c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 RUBCNL LRRK1 WDFY4 ADCY7 MILR1 KYNU	3.49e-07	198	101	7	96883ad8e189a46ed5b7eaafc0543e53682d26ed
ToppCell	COVID-19-lung\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FLNA ATP13A4 DMXL2 TBC1D2B ADCY7 ALCAM KYNU	3.61e-07	199	101	7	155b03b859157013e9142e9248551369127d9204
ToppCell	Control_saline-Hematopoietic_Myeloid-Dendritic_cells-pDC\|Control_saline / Treatment groups by lineage, cell group, cell type	RUBCNL CDH23 WDFY4 ADCY7 MILR1 KYNU EPHB1	3.61e-07	199	101	7	34b95e27581bb127e0b921e9c068dc094cb86b37
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-mature_NK_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGK SLC6A17 BDH2 GLRB HAO2 KYNU	1.70e-06	159	101	6	4000ed0d3b7d488722bcd0042fa2ff4405aaab82
ToppCell	facs-Lung-Endomucin-24m-Lymphocytic-Natural_Killer_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGK SLC6A17 BDH2 GLRB HAO2 KYNU	1.70e-06	159	101	6	7619d0d49738dd08daf01b42664691a5323aa793
ToppCell	LPS-IL1RA-Myeloid-Dendritic_cells-pDC\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSC3 RUBCNL CDH23 WDFY4 MILR1 EPHB1	1.77e-06	160	101	6	dee756a2dc9725520d439e7273c489c2284015d8
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HGF LAMB4 COL7A1 PDGFRA MYOF LRRC15	2.42e-06	169	101	6	c0824a93674e2bff0f09b2d2fab5bab016a2e379
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FLNA SLITRK3 GLRB ALCAM FERMT2 HAO2	2.59e-06	171	101	6	fe0665c5ca01b0b2cc8f20d64587f0847c3d215c
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA MST1R MLIP MMEL1 HMCN2 LRRC15	2.59e-06	171	101	6	82de2885c8ce4fb7776da6a0207b3355c0910121
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA MST1R MLIP MMEL1 HMCN2 LRRC15	2.59e-06	171	101	6	09e653973962fb884878089d281f0947f7a285f6
ToppCell	18-Airway-Immune-Hematopoietic,_B_Cells\|Airway / Age, Tissue, Lineage and Cell class	RUBCNL WDFY4 MILR1 PTPN7 SLC45A3 ATP2A3	3.49e-06	180	101	6	200cecbd8c12a4ec334583fdd5057397504de71e
ToppCell	10x5'-Liver-Lymphocytic_B-Memory_B_cells\|Liver / Manually curated celltypes from each tissue	PCBP3 RUBCNL WDFY4 PLEKHG1 SLC45A3 KDM4B	3.60e-06	181	101	6	a9f4df288c34e3b2b6ed861ac6cda970c3ee08b1
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SIGLEC12 LILRB2 RUBCNL WDFY4 MILR1 KYNU	4.34e-06	187	101	6	23be50d81f4404a609dea821e1a66d221c0e0615
ToppCell	Adult-Mesenchymal-matrix_fibroblast_1_cell-D175\|Adult / Lineage, Cell type, age group and donor	HGF PDGFRA CDH23 LAMC1 HMCN1 KCTD16	4.34e-06	187	101	6	e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	SIGLEC12 LILRB2 LRRK1 WDFY4 MILR1 KYNU	4.48e-06	188	101	6	8fc15c8b78fdd1a578e34325011bc5a87a8aab31
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	HGF BDH2 FAM131A WDFY4 MYOF PPIP5K2	4.62e-06	189	101	6	a2f4f1dd5452f7efb7427919a0b90875cf2e1dc7
ToppCell	10x5'-Liver-Lymphocytic_B\|Liver / Manually curated celltypes from each tissue	RUBCNL WDFY4 PLEKHG1 SLC45A3 TCTN1 KDM4B	4.62e-06	189	101	6	1ebff8185060d78f27f8d887e9adaa5f8faf2196
ToppCell	PBMC-Convalescent-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	HGF BDH2 FAM131A WDFY4 MYOF PPIP5K2	4.62e-06	189	101	6	54a45b0cb7dea01caf1cf0a2664c40e5779a0b61
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor2_(3)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LILRB2 RUBCNL LRRK1 WDFY4 MILR1 KYNU	4.76e-06	190	101	6	081b7bc07b6e5685e8a91b9ae6c1141623723700
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LILRB2 RUBCNL LRRK1 WDFY4 MILR1 KYNU	4.91e-06	191	101	6	bce138f067b8962ecef1ddec6511a3f142d81d78
ToppCell	metastatic_Lymph_Node-Fibroblasts-Myofibroblasts\|metastatic_Lymph_Node / Location, Cell class and cell subclass	HSPG2 LAMB4 PDGFRA PDGFRB HMCN1 LRRC15	4.91e-06	191	101	6	aa43b472bc8362f79ae63f09f1ca764718bbf22c
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_proliferating_myeloid_(8)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LILRB2 RUBCNL LRRK1 WDFY4 MILR1 KYNU	5.06e-06	192	101	6	7e7383093efaadceadd4d1f900c2d39cd690102e
ToppCell	PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_macrophage-im_immature_macrophage1_(2)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LILRB2 RUBCNL LRRK1 WDFY4 MILR1 KYNU	5.06e-06	192	101	6	4e3deefd30adb7bf1eba294610eed3d077aa9418
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL7A1 DSC3 DSG3 RIPK4 MYOF PKM	5.21e-06	193	101	6	7c34abdcb8839b9fb25457a79af6c5e7b9714b21
ToppCell	VE-pDC-\|VE / Condition, Cell_class and T cell subcluster	RUBCNL CDH23 LRRK1 WDFY4 MILR1 EPHB1	5.21e-06	193	101	6	583724de588fcde3aeda056138c522dc0225a387
ToppCell	VE-pDC\|VE / Condition, Cell_class and T cell subcluster	RUBCNL CDH23 LRRK1 WDFY4 MILR1 EPHB1	5.21e-06	193	101	6	bb759dc9ef0ec41d655002f59021d62d62d44289
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 CDH23 LRRK1 WDFY4 ADCY7 KYNU	5.36e-06	194	101	6	badefcec2af86cbcd97305f4843e84db0f3ebc66
ToppCell	PCW_07-8.5-Hematologic_Myeloid\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LILRB2 RUBCNL LRRK1 WDFY4 MILR1 KYNU	5.36e-06	194	101	6	260649f5c4aeaa9cbf5ed5ae5e9f293d75bb0457
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_B-Memory_B_cells\|lymph-node_spleen / Manually curated celltypes from each tissue	RUBCNL LRRK1 WDFY4 PLEKHG1 SLC45A3 KYNU	5.52e-06	195	101	6	8b307079cee67fc1df55277d0cab21ea4b97e552
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 RUBCNL LRRK1 WDFY4 ADCY7 MILR1	5.69e-06	196	101	6	4370473693d2dd4a8c451a4c477eb79baa33ae12
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DMXL2 LILRB2 WDFY4 ADCY7 ALCAM KYNU	5.69e-06	196	101	6	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	10x5'-Liver-Myeloid_Monocytic-Nonclassical_monocytes\|Liver / Manually curated celltypes from each tissue	DMXL2 LILRB2 CDH23 PLXNB2 MYOF KYNU	5.86e-06	197	101	6	b0b4a704e1137f48e2258df17285ed89684ae98d
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	DMXL2 LILRB2 WDFY4 ADCY7 ALCAM KYNU	5.86e-06	197	101	6	e42910a653a1b5bd90c090e9665a84871ed2873f
ToppCell	LPS_IL1RA_TNF-Hematopoietic_Myeloid-Dendritic_cells-pDC\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	RUBCNL WDFY4 ADCY7 MILR1 PTPN7 EPHB1	5.86e-06	197	101	6	8fa38fb95e285f9cc756ec4f32009be4ede09d3c
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HGF COL7A1 PDGFRA PDGFRB LAMC1 TCTN1	5.86e-06	197	101	6	467e7cbf511d3bcc701923603032aaf0bba2736d
ToppCell	10x5'-bone_marrow-Myeloid_Monocytic-Nonclassical_monocytes\|bone_marrow / Manually curated celltypes from each tissue	DMXL2 LILRB2 CDH23 PLXNB2 MYOF KYNU	5.86e-06	197	101	6	dcf1e74b7c21466d38d68f44d404bce14ade2805
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HGF PDGFRA PDGFRB CDH23 LAMC1 HMCN1	6.03e-06	198	101	6	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	COVID-19_Moderate-Non-classical_Monocyte\|World / disease group, cell group and cell class	DMXL2 LILRB2 CDH23 PLXNB2 MYOF KYNU	6.03e-06	198	101	6	8449934e20bb2a34079fb642cae0d4647b9efe51
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LILRB2 LRRK1 WDFY4 ADCY7 MILR1 KYNU	6.03e-06	198	101	6	623f9d64c9e800d2d7f623392bf2f22b563f0249
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HGF PDGFRA PDGFRB LAMC1 ALCAM TCTN1	6.21e-06	199	101	6	30ab0750d51f168b18c434c974d24a4e70f29cc7
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 PDGFRA PDGFRB LAMC1 PAM FERMT2	6.21e-06	199	101	6	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	facs-Trachea-nan-3m-Mesenchymal\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 UAP1 PDGFRA PDGFRB PAM FERMT2	6.21e-06	199	101	6	67f78c070c56e44fba36542041bf7fa1c291807c
ToppCell	facs-Trachea-nan-3m-Mesenchymal-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 UAP1 PDGFRA PDGFRB PAM FERMT2	6.21e-06	199	101	6	1ae244b563f85c1ee8d22698f478c842a4d9c7f5
ToppCell	Control_saline-Hematopoietic_Myeloid-Dendritic_cells\|Control_saline / Treatment groups by lineage, cell group, cell type	RUBCNL CDH23 WDFY4 MILR1 KYNU EPHB1	6.39e-06	200	101	6	1559844b3116d41a69081e4ee89e64744a760181
ToppCell	LPS-antiTNF-Myeloid-Dendritic_cells-pDC\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSC3 RUBCNL CDH23 MILR1 EPHB1	1.14e-05	129	101	5	454bae525f6db3d0dd6347d2a2c3ea9dda9cd212
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))-\|Thalamus / BrainAtlas - Mouse McCarroll V32	DSC3 CDH23 MMEL1 NMBR	1.85e-05	69	101	4	10d5fccc1fa10ffc9051df42dd0e5046d97ec4af
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))\|Thalamus / BrainAtlas - Mouse McCarroll V32	DSC3 CDH23 MMEL1 NMBR	1.85e-05	69	101	4	9d7e911434c6b18327fa7adaec5c449e0c300919
ToppCell	primary_visual_cortex-Neuronal-glutamatergic_neuron-NP\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	UAP1 RUBCNL ZP2 MST1R PROKR2	2.51e-05	152	101	5	b6a7453fbf9f898e4f222b215907c9a110baa2f6
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DSC3 RUBCNL WDFY4 MILR1 EPHB1	2.51e-05	152	101	5	0c6dd41142e4ca1e54ca41e05e42ed29fbf0e570
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK1 WDFY4 GLCCI1 PROKR2 ATP2A3	2.59e-05	153	101	5	3724dd498b982be693ddff9cea7671863acf3ff8
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	LRRK1 WDFY4 GLCCI1 PROKR2 ATP2A3	2.59e-05	153	101	5	d810fc5aff28449ce79b4148558b260878a2c696
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CDH23 MST1R ORC1 MMEL1	2.85e-05	77	101	4	4a0a2f1a021790ff598a8655811eac1c367316b3
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)-\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	CDH23 MST1R ORC1 MMEL1	2.85e-05	77	101	4	459fe29a53b88af77a4ced7b11fa1d0a17fec8e5
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC6A17 BDH2 GLRB HAO2 KYNU	3.83e-05	166	101	5	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_low-phase\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BDH2 FAM131A RIPK4 MDGA1 KYNU	3.83e-05	166	101	5	43f84d3cd58e93ce00c241656c4cba27604b4932
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SLC6A17 BDH2 GLRB HAO2 KYNU	3.83e-05	166	101	5	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	E16.5-Endothelial-Endothelial_lymphatic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM131A HMCN1 SLC45A3 LRRC15 EPHB1	3.94e-05	167	101	5	b93103a868fba63a8910bffb690a6242b9252833
ToppCell	E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM131A HMCN1 SLC45A3 LRRC15 EPHB1	3.94e-05	167	101	5	fcd583b1efd0ac883379982ea8e6c54f2c0be268
ToppCell	E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM131A HMCN1 SLC45A3 LRRC15 EPHB1	3.94e-05	167	101	5	f6bc63138b7239211fa5f27a8dc799b6e022c0f8
ToppCell	facs-Skin-Anagen-24m-Epithelial-bulge_keratinocyte\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPG2 F13B PLEKHG1 HMCN1 EPHB1	3.94e-05	167	101	5	78909f685ccd1321064eb0887caf9263e0e54879
ToppCell	E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAM131A HMCN1 SLC45A3 LRRC15 EPHB1	3.94e-05	167	101	5	26cd8ee5e826e71eaf58d10a906543a6932fb3f9
ToppCell	facs-Heart-LV-3m-Lymphocytic\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL7A1 DSG3 RIPK4 PTPN7 SEPTIN1	4.29e-05	170	101	5	2491f3849e34b0ccd06015fa59d15e3d7963c76d
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMB4 COL7A1 DSC3 DSG3 PKM	4.29e-05	170	101	5	0cc20322cb3e3e7bbd4daad8785c99f80e355c16
ToppCell	5'-Airway_Nasal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	LAMB4 COL7A1 DSC3 DSG3 PKM	4.29e-05	170	101	5	2d880223d01bde4bf777bd6f50b7d2768489075f
ToppCell	Children_(3_yrs)-Immune-B_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	RUBCNL WDFY4 PLEKHG1 ARHGEF10 ATP2A3	4.29e-05	170	101	5	e421f9eedf74baffda1d03707a710ece4b777f29
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination__)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	POGK TAF1C FAM131A GLCCI1 FUBP3	4.41e-05	171	101	5	d1e87478d8c0329e662849823f5c7604f20e1b1a
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HSPG2 PDGFRA PDGFRB BDH2 LRRK1	4.41e-05	171	101	5	2e43fb129ee9bdc3b31febc43c10f959bf0f4a7d
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RUBCNL LRRK1 WDFY4 ATP2A3 EPHB1	4.41e-05	171	101	5	af1c93eb75f45c042ea475d93db56e4da207e31f
ToppCell	frontal_cortex-Non-neuronal-leptomeningeal_cell-VLMC\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HSPG2 PDGFRA PDGFRB BDH2 LRRK1	4.41e-05	171	101	5	e219a1aa59a96e4bc3e2eacf985679174a51de41
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RUBCNL WDFY4 PTPN7 BTN1A1 SEPTIN1	4.54e-05	172	101	5	172e3c78f8e97988a4fd8624514e731282ddc16d
ToppCell	cellseq2-Epithelial-Epithelial_Airway-Basal/Suprabasal-Basal\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	COL7A1 DSC3 DSG3 RIPK4 MYOF	4.54e-05	172	101	5	e9095c3dac66cf93d31f5f88364b565abacb1e2d
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RUBCNL WDFY4 PTPN7 BTN1A1 SEPTIN1	4.54e-05	172	101	5	5fb0ea6145892a258696197b3feed9760187e712
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RUBCNL WDFY4 PTPN7 BTN1A1 SEPTIN1	4.54e-05	172	101	5	2214cc37d7c21b868768d3f74ca4631d339d37b3
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RUBCNL LRRK1 WDFY4 ADCY7 KYNU	4.54e-05	172	101	5	f6b4754a7e4b3e38030316a0ae00d932bfa87e41
ToppCell	5'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	RUBCNL WDFY4 PTPN7 BTN1A1 SEPTIN1	4.54e-05	172	101	5	07620728a6cdeea805e1365e588be096c17a370c
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	RUBCNL ZP2 MST1R PROKR2	4.61e-05	87	101	4	aaca22b97a42a1c4a10c5da708d1462101814386
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Classical_Dendritic_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RUBCNL LRRK1 WDFY4 ADCY7 PTPN7	4.66e-05	173	101	5	73f858f2c45d19b9ec8d99ac02c91551790f670c
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HSPG2 PDGFRA PDGFRB BDH2 LRRK1	4.79e-05	174	101	5	2891ab2fd05eb4bbd239d1a2865f21ef7f2df39e
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HSPG2 PDGFRA PDGFRB BDH2 LRRK1	4.79e-05	174	101	5	eade55f86ef1f7a5355ad65cec3aa6bfc5d3c62d
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l20-1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	UAP1 PDGFRA MYOF PROZ HMCN1	4.79e-05	174	101	5	1d157f7a919c8246e83d8060d2a0017c6c781ef3
ToppCell	TCGA-Colorectal-Recurrent_Tumor\|TCGA-Colorectal / Sample_Type by Project: Shred V9	F2 F13B MLIP LPA HAO2	4.92e-05	175	101	5	7f74961436f88c0e380819095e6104489914d765
ToppCell	Healthy_Control-Myeloid-Mast\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	HSPG2 PTPN7 SLC45A3 FERMT2 ATP2A3	4.92e-05	175	101	5	ca187074adcc9b8bd0fa270e2ede1564c8e6c6cf
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Non-classical_Monocyte\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	DMXL2 LILRB2 WDFY4 ADCY7 KYNU	4.92e-05	175	101	5	e991ffa4d1d278a011592b9915cd35fe76db20cc
ToppCell	TCGA-Colorectal-Recurrent_Tumor-Colorectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	F2 F13B MLIP LPA HAO2	4.92e-05	175	101	5	bee8f31f036dfcf9fc6ed29156554771a9ee3c60
ToppCell	Healthy_Control-Myeloid-Mast-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	HSPG2 PTPN7 SLC45A3 FERMT2 ATP2A3	4.92e-05	175	101	5	eadbbcdf2aef4cee268bc70a7a2c4175d898953b
ToppCell	normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells\|B_lymphocytes / Location, Cell class and cell subclass	DMXL2 LILRB2 CDH23 PLXNB2 EPHB1	5.06e-05	176	101	5	d6e660df92a3d7dd5732171ee623763faf108476
ToppCell	PND14-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	LRP12 DMXL2 FAM78B WDFY4 MYOF	5.06e-05	176	101	5	450c25ec5eeb65425f904e0a25aaafdf5682ef9c
ToppCell	primary_visual_cortex-Non-neuronal-leptomeningeal_cell-VLMC-VLMC_Osr1_Mc5r\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	HSPG2 PDGFRA PDGFRB BDH2 LRRK1	5.20e-05	177	101	5	599cf7f5b774e197a1b43c98e4b9a8c1a618f38a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PDGFRA PDGFRB LILRB2 GRIN2A INTS5	5.48e-05	179	101	5	b70509288aaf4457afd350f6c45784521337ce0d
ToppCell	3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-cDC2\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DSG3 LILRB2 WDFY4 ADCY7 KYNU	5.48e-05	179	101	5	ce95b601bf17ae8167d382a105384b9e65e9407f
Drug	Maprotiline hydrochloride [10347-81-6]; Up 200; 12.8uM; MCF7; HT_HG-U133A	LRP12 PCBP3 TBC1D2B TRIM3 MYOF PTPN7 MTAP ARHGEF10 ATP2A3	1.76e-07	192	100	9	3236_UP
Drug	kalinin	HSPG2 LAMB4 COL7A1 LAMC1 PAM	4.32e-06	55	100	5	CID000032518
Drug	N6-monobutyryl-cAMP	ADCY7 PROZ LPA BTN1A1	1.30e-05	33	100	4	CID000115029
Drug	5,7-Dmpq	PDGFRA PDGFRB	1.91e-05	2	100	2	CID000003139
Drug	3-pyridyl)urea	PDGFRA PDGFRB	1.91e-05	2	100	2	CID000202697
Drug	isocurcumenol	PDGFRA PDGFRB	1.91e-05	2	100	2	CID005255901
Drug	4-nitrophenylurea	PDGFRA PDGFRB	1.91e-05	2	100	2	CID000313520
Drug	Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A	HSPG2 CYP4F8 LILRB2 TAF1C TRIM3 PROZ PKM	2.10e-05	190	100	7	4274_UP
Drug	Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; PC3; HT_HG-U133A	HSPG2 LAMB4 LILRB2 TRIM3 ATP2A3 KYNU EPHB1	2.25e-05	192	100	7	4268_UP
Drug	pheniramine	HGF MST1R PAM	2.28e-05	13	100	3	CID000004761
Drug	Iopanoic acid [96-83-3]; Up 200; 7uM; HL60; HT_HG-U133A	HSPG2 COL7A1 DSG3 LILRB2 MYOF ARHGEF10 ATP2A3	2.40e-05	194	100	7	2965_UP
Drug	Spectinomycin dihydrochloride [21736-83-4]; Up 200; 9.8uM; MCF7; HT_HG-U133A	LRP12 DMXL2 FAM131A MYOF ALCAM HAO2 KDM4B	2.48e-05	195	100	7	3327_UP
Drug	Metanephrine hydrochloride DL [881-95-8]; Up 200; 17.2uM; HL60; HG-U133A	LILRB2 LAMC1 MTAP STXBP3 PAM ATP2A3 KDM4B	2.56e-05	196	100	7	2015_UP
Drug	Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; MCF7; HT_HG-U133A	LAMB4 LRP12 DMXL2 DSC3 MUC5B TRIM3 KDM4B	2.56e-05	196	100	7	4419_DN
Drug	Hymecromone [90-33-5]; Down 200; 22.8uM; MCF7; HT_HG-U133A	LRP12 DMXL2 FAM131A MUC5B DHX35 TCTN1 KDM4B	2.56e-05	196	100	7	3383_DN
Drug	PNU-0251126 [267429-19-6]; Down 200; 1uM; MCF7; HT_HG-U133A	LRP12 DSC3 LILRB2 TRIM3 MYOF PPP2R5B TCTN1	2.65e-05	197	100	7	4714_DN
Drug	Cephalexin monohydrate [23325-78-2]; Up 200; 11uM; MCF7; HT_HG-U133A	HGF HSPG2 LRP12 DMXL2 FAM131A PPP2R5B EPHB1	2.65e-05	197	100	7	5250_UP
Drug	Diethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A	FAM131A TRIM3 DHX35 ALCAM PCBP4 MED12 KDM4B	2.65e-05	197	100	7	7425_DN
Drug	Scoulerine [6451-73-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A	LAMB4 LILRB2 MYOF PPP2R5B ATP2A3 LRRC15 NOVA2	2.74e-05	198	100	7	2891_UP
Drug	Pizotifen malate [5189-11-7]; Up 200; 9.4uM; HL60; HT_HG-U133A	LAMB4 COL7A1 PDGFRA GRIN2A TRIM3 LRRC15 EPHB1	2.74e-05	198	100	7	3134_UP
Drug	Carbetapentane citrate [23142-01-0]; Up 200; 7.6uM; PC3; HT_HG-U133A	HGF PDGFRA DNAH7 TRIM3 NMBR HAO2 NOVA2	2.83e-05	199	100	7	4649_UP
Drug	Solanine alpha [20562-02-1]; Up 200; 4.6uM; MCF7; HT_HG-U133A	HGF LAMB4 DMXL2 LILRB2 DNAH7 HAO2 KDM4B	2.83e-05	199	100	7	4166_UP
Drug	Kawain [500-64-1]; Up 200; 17.4uM; HL60; HT_HG-U133A	COL7A1 KIF1B TRIM3 GLRB PCBP4 FGGY KDM4B	2.83e-05	199	100	7	2337_UP
Drug	Terazosin hydrochloride [63590-64-7]; Down 200; 9.4uM; HL60; HT_HG-U133A	HGF LRP12 DMXL2 LRRK1 TRIM3 MTAP KDM4B	2.83e-05	199	100	7	2530_DN
Drug	N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; MCF7; HT_HG-U133A	HGF COL7A1 DSC3 TAF1C TBC1D2B TRIM3 LPA	2.92e-05	200	100	7	5683_UP
Drug	LMWH	HGF HSPG2 LAMB4 COL7A1 LRP12 DSG3 LAMC1 F2 ADCY7 F13B PROZ LPA	3.41e-05	663	100	12	CID000000772
Drug	Dermatan Sulfate	PDGFRA PDGFRB F2	5.35e-05	17	100	3	ctd:D003871
Drug	Becaplermin	PDGFRA PDGFRB	5.71e-05	3	100	2	DB00102
Drug	LS-64027	PDGFRA PDGFRB	5.71e-05	3	100	2	CID000167812
Drug	6,7-dimethoxyquinoline	PDGFRA PDGFRB	5.71e-05	3	100	2	CID010856252
Drug	AC1NSUA7	PDGFRA PDGFRB	5.71e-05	3	100	2	CID005316441
Drug	c218	HGF MST1R	5.71e-05	3	100	2	CID000818300
Drug	Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A	HGF LAMC1 LRRK1 PLXNB2 ALCAM ATP2A3	7.58e-05	160	100	6	6133_DN
Drug	Bvpam	UAP1 DSG3 F2	1.03e-04	21	100	3	CID000125185
Drug	sporostatin	PDGFRA PDGFRB	1.14e-04	4	100	2	CID006444393
Drug	CT52923	PDGFRA PDGFRB	1.14e-04	4	100	2	ctd:C461979
Drug	Zardaverine [101975-10-4]; Up 200; 15uM; HL60; HT_HG-U133A	COL7A1 LILRB2 RUBCNL FAM131A PRX KYNU	1.28e-04	176	100	6	2926_UP
Drug	CC270	LAMB4 LAMC1 ATP2A3 LRRC15	1.32e-04	59	100	4	CID006918852
Drug	1-aminocyclopropane-1-carboxylic acid	PDGFRA PDGFRB GRIN2A GLRB BTN1A1	1.49e-04	114	100	5	CID000000535
Drug	fluphenazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A	LAMB4 COL7A1 LRP12 TAF1C HAO2 KDM4B	1.73e-04	186	100	6	5597_UP
Drug	Isotretinoin [4759-48-2]; Down 200; 13.4uM; HL60; HT_HG-U133A	ALKBH4 HGF LRRK1 PAM DHX35 ALCAM	1.73e-04	186	100	6	2407_DN
Drug	cyclen	GRIN2A PROZ NMBR	1.76e-04	25	100	3	CID000064963
Drug	2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A	HGF HSPG2 PTPN7 ARHGEF10 PCBP4 ATP2A3	1.78e-04	187	100	6	2669_DN
Drug	Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; HL60; HT_HG-U133A	CYP4F8 LILRB2 GRIN2A ATP2A3 KYNU NOVA2	1.78e-04	187	100	6	3037_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	ALKBH4 COL7A1 PPP2R5B MTAP GLRB KYNU	1.83e-04	188	100	6	5958_DN
Drug	genistein; Up 200; 10uM; HL60; HT_HG-U133A	CYP4F8 TRIM3 PPP2R5B ARHGEF10 HAO2 KYNU	1.89e-04	189	100	6	2695_UP
Drug	glucopiericidin A	PDGFRA PDGFRB	1.89e-04	5	100	2	CID006440812
Drug	diselenium	PDGFRA PDGFRB	1.89e-04	5	100	2	CID006397996
Drug	SCH 13929	PDGFRA PDGFRB	1.89e-04	5	100	2	CID000127725
Drug	selenium chloride	PDGFRA PDGFRB	1.89e-04	5	100	2	CID000066206
Drug	2,6-xylylisocyanide	PPP4C PAM	1.89e-04	5	100	2	CID000076009
Drug	Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; HL60; HG-U133A	ALKBH4 HGF LRRK1 ORC1 MYOF MED12	2.00e-04	191	100	6	1417_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; HL60; HT_HG-U133A	HGF FLNA DMXL2 KIF1B TBC1D2B ATP2A3	2.11e-04	193	100	6	2561_DN
Drug	Carbarsone [121-59-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A	HGF LRP12 TAF1C TRIM3 PRX MYOF	2.11e-04	193	100	6	3250_UP
Drug	acetonitrile	UAP1 PROZ PPP4C PAM	2.17e-04	67	100	4	CID000006342
Drug	Testosterone propionate [57-85-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A	LAMB4 MYOF PTPN7 NMBR KDM4B NOVA2	2.23e-04	195	100	6	5636_UP
Drug	Ethynylestradiol 3-methyl ether [72-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A	LRP12 DMXL2 PCBP3 MYOF KDM4B NOVA2	2.23e-04	195	100	6	3346_UP
Drug	Tobramycin [32986-56-4]; Up 200; 8.6uM; MCF7; HT_HG-U133A	LAMB4 DSC3 DSG3 MUC5B TRIM3 NOVA2	2.23e-04	195	100	6	4162_UP
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A	HSPG2 TAF1C MTAP ATP2A3 MED12 TCTN1	2.23e-04	195	100	6	4360_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Up 200; 8uM; PC3; HT_HG-U133A	LILRB2 TRIM3 PROZ KYNU NOVA2 EPHB1	2.23e-04	195	100	6	4267_UP
Drug	Acyclovir [59277-89-3]; Up 200; 17.8uM; PC3; HT_HG-U133A	LAMB4 PDGFRA TAF1C TBC1D2B ATP2A3 HAO2	2.30e-04	196	100	6	4683_UP
Drug	Sulfapyridine [144-83-2]; Up 200; 16uM; MCF7; HT_HG-U133A	CYP4F8 LILRB2 MUC5B PPP2R5B ARHGEF10 NOVA2	2.30e-04	196	100	6	6101_UP
Drug	Clidinium bromide [3485-62-9]; Up 200; 9.2uM; HL60; HT_HG-U133A	LAMB4 CYP4F8 LILRB2 ARHGEF10 KYNU NOVA2	2.30e-04	196	100	6	2734_UP
Drug	Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; PC3; HT_HG-U133A	COL7A1 TAF1C LRRK1 MYOF FERMT2 MED12	2.30e-04	196	100	6	5812_DN
Drug	6-Furfurylaminopurine [525-79-1]; Up 200; 18.6uM; HL60; HT_HG-U133A	LILRB2 TRIM3 PRX HAO2 NOVA2 EPHB1	2.30e-04	196	100	6	2511_UP
Drug	Ganciclovir [82410-32-0]; Up 200; 15.6uM; MCF7; HT_HG-U133A	HSPG2 LAMB4 COL7A1 MYOF PROZ KDM4B	2.30e-04	196	100	6	3368_UP
Drug	Mianserine hydrochloride [21535-47-7]; Up 200; 13.2uM; HL60; HG-U133A	ALKBH4 HGF LRP12 LILRB2 TAF1C ALCAM	2.36e-04	197	100	6	1385_UP
Drug	Aminopurine, 6-benzyl [1214-39-7]; Up 200; 17.8uM; HL60; HT_HG-U133A	DNAH7 TRIM3 ATP2A3 FGGY KDM4B LRRC15	2.36e-04	197	100	6	2351_UP
Drug	Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A	HSPG2 COL7A1 LILRB2 RUBCNL GRIN2A KDM4B	2.36e-04	197	100	6	4143_UP
Drug	Thyroxine (L) [51-48-9]; Up 200; 5.2uM; MCF7; HT_HG-U133A	LAMB4 COL7A1 CYP4F8 TRIM3 ARHGEF10 KDM4B	2.36e-04	197	100	6	4150_UP
Drug	Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; HL60; HT_HG-U133A	ALKBH4 DMXL2 MYOF MTAP FGGY KDM4B	2.36e-04	197	100	6	2532_DN
Drug	Ungerine nitrate; Down 200; 10.2uM; HL60; HT_HG-U133A	LRP12 KIF1B TBC1D2B LRRK1 MYOF INTS5	2.36e-04	197	100	6	2514_DN
Drug	Heliotrine [303-33-3]; Down 200; 12.8uM; PC3; HT_HG-U133A	LRP12 PDGFRA LRRK1 MTAP TCTN1 KDM4B	2.36e-04	197	100	6	4277_DN
Drug	Droperidol [548-73-2]; Up 200; 10.6uM; PC3; HT_HG-U133A	HSPG2 LILRB2 TBC1D2B DNAH7 ARHGEF10 NOVA2	2.36e-04	197	100	6	4629_UP
Drug	Minocycline hydrochloride [13614-98-7]; Up 200; 8uM; MCF7; HT_HG-U133A	LAMB4 LRP12 DSC3 FAM131A MTAP MED12	2.36e-04	197	100	6	5496_UP
Drug	1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one	HSPG2 FLNA PDGFRB LAMC1 LRRK1 PLXNB2 IGFBPL1 MYOF	2.42e-04	373	100	8	ctd:C540355
Drug	Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; PC3; HT_HG-U133A	LAMB4 TAF1C TRIM3 PTPN7 ATP2A3 HAO2	2.43e-04	198	100	6	6625_UP
Drug	Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A	LAMB4 LRP12 DNAH7 TRIM3 PPP2R5B ARHGEF10	2.43e-04	198	100	6	6088_UP
Drug	Isoniazid [54-85-3]; Up 200; 29.2uM; PC3; HT_HG-U133A	HSPG2 COL7A1 DNAH7 TRIM3 PAM KYNU	2.43e-04	198	100	6	2083_UP
Drug	Vincamine [1617-90-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	LAMB4 COL7A1 TRIM3 F13B MST1R PPP2R5B	2.43e-04	198	100	6	3976_UP
Drug	Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; HL60; HT_HG-U133A	DSC3 FAM131A TRIM3 MYOF MTAP KDM4B	2.43e-04	198	100	6	2542_DN
Drug	Dilazep dihydrochloride [20153-98-4]; Up 200; 6uM; PC3; HT_HG-U133A	SLITRK3 TRIM3 PRX PROZ KDM4B LRRC15	2.43e-04	198	100	6	3665_UP
Drug	Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A	LRP12 CYP4F8 TBC1D2B TRIM3 BSN HAO2	2.43e-04	198	100	6	5390_UP
Drug	S(-)Eticlopride hydrochloride [97612-24-3]; Up 200; 10.6uM; MCF7; HT_HG-U133A	LILRB2 TRIM3 PRX PPP2R5B ARHGEF10 ALCAM	2.43e-04	198	100	6	3393_UP
Drug	Cephalosporanic acid, 7-amino [957-68-6]; Up 200; 14.6uM; MCF7; HT_HG-U133A	LAMB4 TAF1C MUC5B MYOF KYNU KDM4B	2.43e-04	198	100	6	3258_UP
Drug	Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A	HGF LAMB4 MST1R PTPN7 NMBR NOVA2	2.43e-04	198	100	6	3970_UP
Drug	4-picoline	PROZ PPP4C PAM	2.49e-04	28	100	3	CID000007963
Drug	2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; HL60; HT_HG-U133A	LAMB4 COL7A1 TAF1C FGGY KDM4B NOVA2	2.49e-04	199	100	6	3063_DN
Drug	Methiazole; Up 200; 15uM; MCF7; HT_HG-U133A	LRP12 PRX PROZ ALCAM KYNU KDM4B	2.49e-04	199	100	6	3878_UP
Drug	Dacarbazine [4342-03-4]; Up 200; 22uM; MCF7; HT_HG-U133A	HGF LAMB4 DSC3 LILRB2 MST1R NOVA2	2.49e-04	199	100	6	6816_UP
Drug	Ethosuximide [77-67-8]; Up 200; 28.4uM; HL60; HG-U133A	ALKBH4 LILRB2 TAF1C ARHGEF10 DHX35 PCBP4	2.49e-04	199	100	6	1433_UP
Drug	(S)-(-)-Atenolol [93379-54-5]; Up 200; 15uM; MCF7; HT_HG-U133A	HGF LRP12 DSC3 LILRB2 ARHGEF10 ATP2A3	2.49e-04	199	100	6	6444_UP
Drug	Mephenytoin [50-12-4]; Up 200; 18.4uM; MCF7; HT_HG-U133A	DSC3 TBC1D2B MYOF ATP2A3 KDM4B NOVA2	2.49e-04	199	100	6	3580_UP
Drug	Terazosin hydrochloride [63590-64-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A	HGF DSC3 PTPN7 PPP2R5B PROZ NMBR	2.49e-04	199	100	6	6092_UP
Drug	Tadjakonine [11087-94-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	TRIM3 PRX MTAP PAM DHX35 NOVA2	2.49e-04	199	100	6	2820_UP
Drug	Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; HL60; HT_HG-U133A	HSPG2 COL7A1 PDGFRA PPP2R5B ATP2A3 NOVA2	2.49e-04	199	100	6	3113_UP
Drug	chlorpropamide; Down 200; 100uM; MCF7; HG-U133A	ALKBH4 DMXL2 TAF1C RIPK4 TCTN1 KDM4B	2.56e-04	200	100	6	141_DN
Drug	2-Chloropyrazine [14508-49-7]; Down 200; 35uM; PC3; HT_HG-U133A	TAF1C TBC1D2B DNAH7 MYOF GLRB KYNU	2.56e-04	200	100	6	5750_DN
Drug	Rilmenidine hemifumarate [54187-04-1]; Up 200; 8.4uM; MCF7; HT_HG-U133A	LRP12 LILRB2 LRRK1 TRIM3 PRX ARHGEF10	2.56e-04	200	100	6	5532_UP
Drug	Liothyronine [6893-02-3]; Up 200; 6.2uM; HL60; HT_HG-U133A	LAMB4 DSC3 DSG3 FAM131A LPA GLRB	2.56e-04	200	100	6	2984_UP
Disease	FG syndrome (is_implicated_in)	FLNA MED12	3.40e-05	3	100	2	DOID:14711 (is_implicated_in)
Disease	FG SYNDROME 4 (disorder)	FLNA MED12	3.40e-05	3	100	2	C1845546
Disease	platelet-derived growth factor receptor alpha measurement	PDGFRA F13B	3.40e-05	3	100	2	EFO_0021844
Disease	FG SYNDROME 2	FLNA MED12	3.40e-05	3	100	2	C1845902
Disease	FG SYNDROME 3	FLNA MED12	3.40e-05	3	100	2	C1845567
Disease	FG syndrome	FLNA MED12	3.40e-05	3	100	2	C0220769
Disease	Deep Vein Thrombosis	F2 F13B LPA	4.81e-05	21	100	3	C0149871
Disease	Venous Thrombosis	F2 F13B LPA	4.81e-05	21	100	3	C0042487
Disease	FG syndrome	FLNA MED12	6.79e-05	4	100	2	cv:C0220769
Disease	medulloblastoma (is_marker_for)	PDGFRA KDM4B	1.13e-04	5	100	2	DOID:0050902 (is_marker_for)
Disease	Insulinogenic index measurement	PAM PPIP5K2	1.13e-04	5	100	2	EFO_0009961
Disease	Malignant Cystosarcoma Phyllodes	FLNA MED12	1.13e-04	5	100	2	C0600066
Disease	oligohydramnios (biomarker_via_orthology)	PDGFRA PDGFRB	1.13e-04	5	100	2	DOID:12215 (biomarker_via_orthology)
Disease	Phyllodes Tumor	FLNA MED12	1.13e-04	5	100	2	C0010701
Disease	hypertension (biomarker_via_orthology)	HSPG2 CYP4F8 PDGFRA PDGFRB PKM ATP2A3	1.27e-04	227	100	6	DOID:10763 (biomarker_via_orthology)
Disease	Leydig cell tumor (is_marker_for)	PDGFRA PDGFRB	3.14e-04	8	100	2	DOID:2696 (is_marker_for)
Disease	intraocular pressure measurement	LRP12 PCBP3 F2 GLCCI1 MYOF ANAPC1 ALCAM FERMT2	3.45e-04	509	100	8	EFO_0004695
Disease	familial Mediterranean fever (is_marker_for)	F2 LPA	4.03e-04	9	100	2	DOID:2987 (is_marker_for)
Disease	prostate adenocarcinoma (is_marker_for)	PDGFRA PAM	5.03e-04	10	100	2	DOID:2526 (is_marker_for)
Disease	daytime rest measurement	PCBP3 GRIN2A KCTD16 PAM MDGA1 EPHB1	5.15e-04	295	100	6	EFO_0007828
Disease	hyperhomocysteinemia (implicated_via_orthology)	GRIN2A F2	6.13e-04	11	100	2	DOID:9279 (implicated_via_orthology)
Disease	vascular dementia (is_marker_for)	GRIN2A LPA	6.13e-04	11	100	2	DOID:8725 (is_marker_for)
Disease	Thromboembolism	F2 LPA	7.34e-04	12	100	2	C0040038
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 CDH23	8.66e-04	13	100	2	C1846647
Disease	hyperglycemia (is_marker_for)	HSPG2 F2	8.66e-04	13	100	2	DOID:4195 (is_marker_for)
Disease	Spondyloepiphyseal Dysplasia	HSPG2 FLNA	1.32e-03	16	100	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	HSPG2 FLNA	1.32e-03	16	100	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	HSPG2 FLNA	1.32e-03	16	100	2	C4551479
Disease	Schwartz-Jampel Syndrome	HSPG2 FLNA	1.32e-03	16	100	2	C0036391
Disease	Melnick-Needles Syndrome	HSPG2 FLNA	1.32e-03	16	100	2	C0025237
Disease	Van Buchem disease	HSPG2 FLNA	1.50e-03	17	100	2	C0432272
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 FLNA	1.87e-03	19	100	2	DOID:2256 (is_implicated_in)
Disease	Osteochondrodysplasias	HSPG2 FLNA	1.87e-03	19	100	2	C0029422
Disease	carotid artery disease (is_marker_for)	HGF HSPG2	1.87e-03	19	100	2	DOID:3407 (is_marker_for)
Disease	Dyschondroplasias	HSPG2 FLNA	1.87e-03	19	100	2	C0013366
Disease	Multiple Epiphyseal Dysplasia	HSPG2 FLNA	2.08e-03	20	100	2	C0026760
Disease	metabolite measurement	WDFY4 MYOF ALCAM MDGA1 PCBP4 HAO2 EPHB1	2.99e-03	560	100	7	EFO_0004725

Protein segments in the cluster

Peptide	Gene	Start	Entry
VECVGSTRGVLIEPV	PPP2R5B	111	Q15173
PSRSVLCQEVEVAIP	ALKBH4	221	Q9NXW9
SDVPTICVGTEEGSI	ARHGEF10	986	O15013
TICPIADGPERVTVI	BTN1A1	471	Q13410
PCRTASQVPVEGIAI	ATP13A4	581	Q4VNC1
TIDQCPTRIEETSPI	FAM78B	26	Q5VT40
ECLGTTRPVVPIDSS	PAM	41	P19021
SVSRVPCNVEGISPE	GLCCI1	291	Q86VQ1
IVSQQSTARPGCIIE	DMXL2	821	Q8TDJ6
RGTLCTISERVETQP	ADCY7	651	P51828
VSIPEDCPVGQRVAT	CDH23	1426	Q9H251
ILTEVPITPETTCRD	PPP1R13B	16	Q96KQ4
GAPESVIERCSSVRV	ATP2A3	516	Q93084
TCPSEVSGTILQERE	MLIP	96	Q5VWP3
RIVTENIPCGTTGTT	MUC5B	936	Q9HC84
VTTACGSLREEIQPG	MTAP	91	Q13126
GCAVLQVSPVTETRT	RUBCNL	276	Q9H714
RSGLRCEEGVTVTTP	HSPG2	3916	P98160
GAVEPICSVNTPREV	PTPN7	56	P35236
PTLVRTTGQVCTIDP	ANAPC1	811	Q9H1A4
VTVREGSPAELQCEV	MDGA1	451	Q8NFP4
QTVRCTAEGTPLPDI	PDGFRA	431	P16234
VTERVICPISSVPGN	DSG3	961	P32926
EVACTSVPSGPRNVI	EPHB1	316	P54762
ITISEGSCPERITTI	PCBP4	51	P57723
PASDGTTTELVIRCV	NMBR	31	P28336
DEENCPVIVPTRVIT	LRP12	481	Q9Y561
QERPTNREETGIICP	FER1L6-AS1	61	Q8NA97
ASSPQETVICGPVTR	KCTD16	321	Q68DU8
ELPGVQSSDEIICSR	LRRK1	316	Q38SD2
ALRCQATGEPTPTIE	HMCN2	4321	Q8NDA2
ERSNSGEVIVTLEPC	KIF1B	586	O60333
GTEPCVVRRIADSSV	BSN	2571	Q9UPA5
TPLSELSVQCNRGEV	F13B	496	P05160
RVEGEAVICNSPSSI	PLXNB2	566	O15031
IQIASESSGIPERPC	FUBP3	111	Q96I24
QVGLSCEVRAVPTPV	IGFBPL1	171	Q8WX77
VERECGTIIEGVNTP	KDM4B	161	O94953
SPVVTSGGRVTLQCE	LILRB2	131	Q8N423
GIICTIGPASRSVET	PKM	46	P14618
RDVITCEPQGSLIDT	MED12	1646	Q93074
TPVHISTLQVGETRC	GLRB	391	P48167
ISRCEGDTTPTIVNL	HGF	466	P14210
TPICLEVPSRVTVDN	POGK	366	Q9P215
PRGIPEAQEVSEVCT	MMEL1	76	Q495T6
PPEVVCTKRSNTGEE	NOVA2	16	Q9UNW9
PGTTERVCLVQGTAE	NOVA2	76	Q9UNW9
EESVPEVGSRPCVST	MILR1	286	Q7Z6M3
ISEGNCPERIVTITG	PCBP3	81	P57721
CPERIVTITGPTDAI	PCBP3	86	P57721
RAVTISGTPDAIIQC	PCBP3	176	P57721
SVTLTCEVTGNPVPE	HMCN1	2496	Q96RW7
VDTSINIECRATGTP	HMCN1	3356	Q96RW7
RRCLTQPVEDQGVST	MYO15B	1211	Q96JP2
CTRGSPQETTVLLVD	ORC1	606	Q13415
EGTRCIQVEITPTSS	FAM126A	296	Q9BYI3
GEVEQDVSTSIPSCI	IFTAP	126	Q86VG3
TVGVVCATDRDEPDT	DSC3	261	Q14574
EGQPVTSRLAVICGT	FGGY	281	Q96C11
QVPVTEGCDPSRVRV	FLNA	1346	P21333
DTCVILTVEGRTFPV	DHX35	231	Q9H5Z1
GCTQDVVLPDSRVIP	CYP4F8	401	P98187
VIQGVCLSRPETTET	DNAH7	2186	Q8WXX0
RPVRQGSVEPESDCS	FAM131A	231	Q6UXB0
TRCSDTEGTVVAPPT	LPA	1691	P08519
IDVTDPESCSRVTGE	LAMB4	976	A4D0S4
VTVVATNTCGTPPEE	LAMC1	61	P11047
SVTQTPVCPRGLADV	COL7A1	1041	Q02388
PQETCSGTEVERPRQ	C1orf127	446	Q8N9H9
QITTDITPECLVSPR	FERMT2	511	Q96AC1
EVTRQIGDALPVSCT	ALCAM	341	Q13740
EITEITIPCRVTDPQ	PDGFRB	141	P09619
QVECTGARIVAVPTP	LRRC15	36	Q8TF66
GPVRQVVTCTVQGES	TAF1C	266	Q15572
RTTIQGEEISAPICI	HAO2	61	Q9NYQ3
SSVSVVGDVLCRSPE	SLITRK3	581	O94933
TRPVTLVEGEECGQV	PROZ	316	P22891
TTQGLAVPDTVREAC	INTS5	421	Q6P9B9
IVTVCATLDENPGVR	STXBP3	181	O00186
RVTCPLSSPQEITSE	RIPK4	316	P57078
PESVTVQEGLCVSVP	SIGLEC12	156	Q96PQ1
CDVSVRVVVGEPTEA	SLC45A3	466	Q96JT2
CPGTVDTPSLQERIQ	BDH2	176	Q9BUT1
IITETERLGCSEEGP	CLHC1	31	Q8NHS4
ESIPFAVVGSCEVVR	SEPTIN1	226	Q8WYJ6
APVVECSITGDSSRV	WDR88	146	Q6ZMY6
VEVIEGTLQCPESGR	TRMT112	91	Q9UI30
CLETREGAVSVVVPT	PRX	311	Q9BXM0
VVTEERGILPSTCPD	ZNF558	101	Q96NG5
TTEQDCLALEGVRTP	TCTN1	416	Q2MV58
VSTPGVQDPERELTC	WDFY4	531	Q6ZS81
DLRTNGVPTTEEVDC	PROKR2	366	Q8NFJ6
EKTNPTEPVGVVCRV	UAP1	281	Q16222
TTDPTVRRQECSIPV	F2	171	P00734
CPVVRNGSVAVVEAE	SLC6A17	181	Q9H1V8
NTCPPEIGTSDRTRE	PLEKHG1	616	Q9ULL1
DPLPGSVQRCSVVVS	PLEKHG1	1136	Q9ULL1
DDSPPERQIVVGICS	PPIP5K2	36	O43314
NVQRVDSPVTVCGDI	PPP4C	41	P60510
ESPVSIVTGELCTQD	ZP2	361	Q05996
DCVASPLGTRVTVVE	MST1R	176	Q04912
TPVCSEDQGPTREVI	TBC1D2B	551	Q9UPU7
RCVSVQTDPTDEIPT	SON	91	P18583
VCRQTSILPEQGVSA	TRIM3	61	O75382
TTSVRAVPAECEGLT	WNK3	981	Q9BYP7
VEERGCQLTITFSVP	KYNU	396	Q16719
SPSLVVECGGERVES	MYOF	1326	Q9NZM1
DIDPLTETCVRNTVP	GRIN2A	421	Q12879